Morning All!
Just one this morning…
Porvair ( Porvair (LON:PRV) ) – 450p – £216.8m – PER 24.6
Trading Update And Acquisition – Revenue up 6%, Profits expected to be ahead of managements expectations. Net Cash £9.7m (£13.6m last time). Small acquisition made and order books are healthy.
A nice update but for me this doesn’t look anything better than an average company. Considering the PER of 24.6, it’s not something I am going to get overly excited about.
A great weekend to all!
My morning smallcap tweet:
Porvair (LON:PRV), Angle (LON:AGL)
Porvair (PRV) trading - FY earnings will beat mgmt expectations.
Angle (AGL) University of Southern California has shown Parsortix liquid biopsy can detect metastatic breast cancer from a blood sample. "Angle is working towards an FDA clearance of the Parsortix system in metastatic breast cancer with the required analytical and clinical studies targeted for completion by 30 June 2018. ANGLE is seeking to become the first company ever to receive FDA clearance for a medical device to harvest cancer cells from patient blood for subsequent analysis."
